Global Oncology Academy

Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Global Oncology Academy
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
- Daniel J. George, MD
ADT Monotherapy for mHSPC: How to Identify the Right Patients
ADT Monotherapy for mHSPC: How to Identify the Right Patients
Global Oncology Academy
ADT Monotherapy for mHSPC: How to Identify the Right Patients
- Daniel J. George, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Global Oncology Academy
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- Daniel J. George, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Project Oncology®
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
- Jennifer Caudle, DO
- Doris M. Ponce, MD, MS
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Global Oncology Academy
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
- Paolo Tarantino, MD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's Roundtable
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
- Peter Buch, MD, FACG, AGAF, FACP
- A. Mark Fendrick, MD

Medical News

Medical News
AI in Medical Imaging: Facial Analysis for Biological Age Estimation and Cancer Prognosis
05/09/2025
Read more
Medical News
Next-Generation CAR T Cell Therapy: Optimizing Treatment for Resistant Lymphoma
05/08/2025
Read more
Medical News
Artificial Intelligence in Imaging: Enhancing Prostate Cancer Detection
05/07/2025
Read more
Medical News
Precision Medicine and Soft Tissue Sarcomas: Improved Treatment Selection
05/07/2025
Read more

See more news

CME/CE

First-line Chemotherapy Options in Metastatic PDAC
First-line Chemotherapy Options in Metastatic PDAC
MinuteCE®
First-line Chemotherapy Options in Metastatic PDAC
0.25 program credits
- Eileen O’Reilly, MD
0.25 program credits
Second-line Chemotherapy Options in Metastatic PDAC
Second-line Chemotherapy Options in Metastatic PDAC
MinuteCE®
Second-line Chemotherapy Options in Metastatic PDAC
0.25 program credits
- Efrat Dotan, MD
0.25 program credits
MinuteCE®
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
0.25 credits 2 episodes
- Eileen O’Reilly, MD
- Efrat Dotan, MD
0.25 credits 2 episodes
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
MinuteCE®
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
1.00 program credit
- Fortunato Ciardiello, MD, PhD
- Jenny Seligmann, MBChB, PhD
1.00 program credit

Clinical Practice

Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Global Oncology Academy
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
- Megan Kruse, MD
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Global Oncology Academy
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
- Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
- Ihtisham Ahmad
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Global Oncology Academy
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
- Paolo Tarantino, MD

Programs

Cost Considerations for Colorectal Cancer Screening: Examining the Data
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's Roundtable
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Project Oncology®
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
- Robert Walker, PharmD
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Project Oncology®
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
- Fernando López-Ríos, MD, PhD
- Christian Rolfo, MD, PhD
- Charlie Gourley, MD, PhD
Targeting CD123 in AML: The Latest Therapeutic Advancements
Targeting CD123 in AML: The Latest Therapeutic Advancements
Project Oncology®
Targeting CD123 in AML: The Latest Therapeutic Advancements
- Jennifer Caudle, DO
- Naval Daver, MD